Jaime Peykoff Follicular Lymphoma Initiative
Follicular lymphoma (FL) is a slow-growing or indolent form of non-Hodgkin lymphoma (NHL) that accounts for 20 to 30 percent of all NHL cases. While typically an indolent form of lymphoma, FL remains incurable and a continuing challenge for researchers and clinicians. Although most patients respond to the current standard of care, many will require treatment throughout their lifetime; other patients’ inability to achieve a complete remission or those whose disease progresses early results in poorer long-term outcomes.
Established in 2020 through the generosity of the Peykoff Family and Niagara Cares, the $10 million Initiative is poised to transform the follicular lymphoma treatment landscape for tens of thousands of patients by harnessing the Lymphoma Research Foundation’s unique resources, convening the world’s experts in follicular lymphoma research and patient care, and driving direct investment in clinical research.
International Follicular Lymphoma Scientific Workshop
Building upon more than two decades’ experience as a convener of international scientific consortia and disease-specific research workshops, the Foundation will develop an international Scientific Workshop to drive collaboration. Follicular lymphoma thought leaders would share early research findings, discuss the results of pivotal clinical trials, and engage in planning exercises designed to advance FL research.
Clinical Research Grants
The Lymphoma Research Foundation is committed to funding the most promising lymphoma researchers who have the greatest potential to improve patient care and, ultimately, to improve patient outcomes. Under the expert leadership of the Jaime Peykoff Follicular Lymphoma Initiative Steering Committee and the Foundation’s Scientific Advisory Board (SAB), the Foundation will fund both Clinical Investigator Career Development Awards and Senior Investigator Grants to attract senior and early-career investigators and train them in the field of FL research. The Foundation convened an expert panel to develop this research program; click here to read the resulting white paper which will guide the effort.
Help Accelerate the Pace of Lymphoma Research
We are proud to announce the Jaime Peykoff Follicular Lymphoma Initiative, made possible by the generosity of the Peykoff Family. We invite you to express your support by making a gift in honor of Jaime Peykoff and all those whose lives will be touched by this groundbreaking work.
Steering Committee
Chair
Ann S. LaCasce, MD, MMSC
Dana-Farber Cancer Institute
Stephen Ansell, MD, PhD
Mayo Clinic, Rochester
John P. Leonard, MD
Weill Cornell Medicine
Loretta Nastoupil, MD
University of Texas MD Anderson Cancer Center
Laura Pasqualucci, MD
Columbia University Medical Center
Laurie Sehn, MD, MPH
BC Cancer, Vancouver
Sonali M. Smith, MD
The University of Chicago
John Timmerman, MD
UCLA Jonsson Comprehensive Cancer Center
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center